David Solit, M.D.

Dr. Solit is the Geoffrey Beene Chair for Cancer Research and the Director of the Marie-Josée & Henry R. Kravis Center for Molecular Oncology (“CMO”) at Memorial Sloan Kettering Cancer Center. A member of the Genitourinary Oncology Service, he is a medical oncologist specializing in the treatment of prostate, bladder, kidney, testis and other related cancers. Dr. Solit was formerly the Chief of the MSKCC Developmental Therapeutics Service during which time he initiated a program to promote pan-cancer Basket trials. His laboratory research focuses on the identification of molecular predictors of drug response and mechanisms of drug resistance, with a focus on BRAF, MEK and other kinases inhibitors. As Director of the CMO, he leads a multidisciplinary team of clinicians, geneticists, bioinformaticians, and laboratory scientists, which seek to integrate molecular and clinical information to develop therapies that are individualized to each patient’s cancer. He is a member of the American Society of Clinical Investigation and the Association of American Physicians.